Through research, innovation, and development, we’re elevating the standard of care through quality clinical evidence in partnership with clinicians, physicians, hospitals, and professional associations. Our clinical publications emphasize our ongoing commitment to improving procedure efficiency, and saving lives.
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
This study aimed to externally validate a previously developed risk score for predicting treatment failure after salvage focal therapy in prostate cancer patients.
Open publication
Dora et al, Journal of Endourology (2022)
This study determined TULSA is a safe and effective method for prostate tissue ablation in men with primary prostate cancer and has also been shown to provide significant relief from urinary symptoms while treating PCa in a single, low-morbidity procedure.
Open publicationGet the latest tips for all ages and stages. Subscribe to our newsletter.
